As of 2:31pm ET
| +0.05 / +6.33%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 4.38, with a high estimate of 5.75 and a low estimate of 3.00. The median estimate represents a +420.83% increase from the last price of 0.84.
The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.